Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties

Documenti analoghi

• Unique Nerve Tissue‐Restricted T‐Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy
  di: G. G. A. van Lieverloo, et al.
  Pubblicazione: (2025)
• Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK : The Impact of Ethnicity
  di: Zeinab Rajabally, et al.
  Pubblicazione: (2025)
• Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape
  di: Luis Querol, et al.
  Pubblicazione: (2025)
• Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report
  di: Edoardo Dalmato Schilke, et al.
  Pubblicazione: (2025)
• Climatic and Geographic Variations of Antecedent Infections in Guillain–Barré Syndrome: A Long‐Term Longitudinal Analysis From Bangladesh
  di: Mantaka Rahman, et al.
  Pubblicazione: (2026)